IDIBAPS

AB-Biotics acquires patent for predicting antipsychotic-induced extrapyramidal symptoms

Tuesday, October 29, 2013

The Spanish biotech company AB-Biotics has acquired the rights to a patent which predicts the high or low risk of a patient treated with antipsychotic drugs developing extrapyramidal symptoms. Side effects induced by antipsychotic drugs affect patient movement and include muscle rigidity, parkinsonism, akinesia (inability to initiate movement) and akathisia (inability to remain motionless).

[Read More]